Nasdaq suspends Windtree (WINT): -80% in 24 hours, moving to OTC and BNB strategy in jeopardy

Related

Bitfire Group Joins Hong Kong Web3 Festival as Diamond Sponsor

Hong Kong, 4th April 2026 — Hong Kong Web3 Festival 2026...

ZA Bank Confirms Participation at Hong Kong Web3 Festival

Hong Kong, 4th April 2026 — Hong Kong Web3 Festival 2026...

MARA Bitcoin pivot: miner shifts to AI infra after $1.1B sale, 15% layoffs

As it races to reposition itself in digital infrastructure,...

Bitcoin Price Under Pressure: Can the Decline Continue?

After last night’s drop, hypotheses are beginning to circulate...

Share

The suspension from Nasdaq for Windtree Therapeutics (ticker WINT), due to non-compliance with listing requirements and accompanied by an intraday collapse of –80%, has sparked strong fears among investors and raised questions about the recent initiative of treasury in BNB (initial commitment of $60 million with potential up to $200 million), indicating an already fragile financial balance.

According to the collected data, the stock went from about $0.48 before the notice to $0.11 at the close on August 21, 2025, confirming the very substantial intraday loss. Industry analysts monitoring small-cap biotech companies note that similar situations typically lead to a compression of capitalization and a significant reduction in liquidity in the first weeks following the delisting.